跳至主要内容
临床试验/CTRI/2014/11/005213
CTRI/2014/11/005213已完成不适用

A Questionnaire based Survey of Psychiatrists practicing in India to Determine their Diagnostic and Management Practices for Bipolar Disorders in Clinical Practice

Glaxosmithkline Pharmaceuticals Limited1 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2014年11月25日最近更新:

试验速览

阶段
不适用
状态
已完成
入组人数
500
试验地点
1
主要终点
The usage pattern of pharmacological and non-pharmacological interventions by Psychiatrists practicing in India for bipolar disorders

研究概览

简要总结

Bipolar Disorder is a serious disorder of mood that is associated with considerable psychosocial and economic morbidity. Misdiagnosis of the illness as recurrent unipolar depression is common, leading to initiation of medicines that adversely affect the condition’s course. Despite their widespread use, considerable uncertainty and controversy remains about the use of antidepressant drugs in the management of depressive episodes.

There are limited data from India to suggest whether availability of newer options [atypical antipsychotics (mono/combination with mood stabilizers), antiepileptic agents (for acute mania), and psychosocial interventions for maintenance] have reflected in prescription behaviour of psychiatrists in treatment of BPD. Moreover, India specific data are missing with reference to treatment recommended in guidelines and prevailing in the clinical practice.

There is significant unmet medical need in understanding various important aspects in the management of BPD such as treatment of different phases of BPD; place of combination medications; treatment for mixed states, hypomania, rapid cycling; place of antidepressants in treating bipolar depression; use of psychological therapies and electroconvulsive therapy (ECT); etc. At present, there are scarce published data on the prevalent diagnostic and treatment practices for patients suffering from BPD among psychiatrists practicing in India. Hence, this study will be conducted to gather data on prescription patterns of psychiatrists practicing in India for acute and maintenance phases of BPD and identify gaps (if any) between guideline recommendations and  treatments most frequently chosen by them.

研究设计

研究类型
Observational

入排标准

年龄范围
27.00 Year(s) 至 75.00 Year(s)(—)
性别
All

入选标准

  • 1.Psychiatrists (with postgraduate degree/diploma/fellowship in psychiatry) practicing for at least 3 years after post graduation in India.
  • 2.Psychiatrists willing to sign the consent form 3.Psychiatrists willing to complete the survey.

排除标准

  • Psychiatrists practicing for fewer than 3 years after post graduation in India.
  • 2.Psychiatrists not willing to sign the consent form 3.Psychiatrists not willing to complete the survey questionnaire.

结局指标

主要结局

The usage pattern of pharmacological and non-pharmacological interventions by Psychiatrists practicing in India for bipolar disorders

时间窗: 2 months

次要结局

  • 1.Determination of gaps (if any) in CANMAT guidelines and treatment chosen in the clinical practice in India(2.Determination of the extent of use of antidepressants in bipolar disorder by psychiatrists practising in India)

研究者

申办方类型
Pharmaceutical industry-Global

研究点 (1)

Loading locations...

相似试验